BioCryst Pharmaceuticals
BCRX
BCRX
238 hedge funds and large institutions have $915M invested in BioCryst Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 84 increasing their positions, 71 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.58% less ownership
Funds ownership: 87.89% → 87.32% (-0.58%)
15% less capital invested
Capital invested by funds: $1.08B → $915M (-$163M)
16% less call options, than puts
Call options by funds: $7.81M | Put options by funds: $9.31M
Holders
238
Holding in Top 10
5
Calls
$7.81M
Puts
$9.31M
Top Buyers
| 1 | +$23.9M | |
| 2 | +$12.3M | |
| 3 | +$9.79M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$8.21M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$5.7M |
Top Sellers
| 1 | -$21.7M | |
| 2 | -$11.9M | |
| 3 | -$11.8M | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$6.15M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.47M |